Traders sold shares of Humana Inc (NYSE:HUM) on strength during trading on Monday. $124.74 million flowed into the stock on the tick-up and $153.63 million flowed out of the stock on the tick-down, for a money net flow of $28.89 million out of the stock. Of all companies tracked, Humana had the 31st highest net out-flow for the day. Humana traded up $0.15 for the day and closed at $249.65
HUM has been the topic of a number of analyst reports. Citigroup lowered their target price on Humana from $397.00 to $362.00 and set a “buy” rating on the stock in a report on Thursday, February 7th. Morgan Stanley set a $331.00 target price on Humana and gave the company a “buy” rating in a report on Thursday. Cowen upgraded Humana from a “market perform” rating to an “outperform” rating and set a $275.02 target price on the stock in a report on Friday, January 11th. Stephens started coverage on Humana in a report on Monday, January 14th. They set an “overweight” rating and a $336.00 target price on the stock. Finally, Barclays restated a “buy” rating and set a $351.00 price objective on shares of Humana in a report on Sunday, January 6th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $337.26.
The company has a quick ratio of 1.68, a current ratio of 1.65 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $33.84 billion, a PE ratio of 17.16, a price-to-earnings-growth ratio of 1.03 and a beta of 0.88.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.30 by $0.18. Humana had a return on equity of 20.77% and a net margin of 2.99%. The business had revenue of $16.11 billion for the quarter, compared to analysts’ expectations of $15.67 billion. During the same quarter last year, the firm earned $3.36 earnings per share. The business’s revenue was up 12.8% on a year-over-year basis. Research analysts forecast that Humana Inc will post 17.56 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 0.88%. The ex-dividend date is Thursday, June 27th. Humana’s dividend payout ratio (DPR) is currently 15.12%.
In related news, insider Christopher H. Hunter sold 15,586 shares of the stock in a transaction on Monday, February 25th. The stock was sold at an average price of $305.24, for a total value of $4,757,470.64. Following the transaction, the insider now directly owns 28,100 shares of the company’s stock, valued at approximately $8,577,244. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Roy A. Beveridge sold 8,278 shares of the stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total value of $2,542,670.48. Following the completion of the transaction, the insider now directly owns 12,409 shares in the company, valued at $3,811,548.44. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the stock. Moody National Bank Trust Division purchased a new position in Humana in the fourth quarter valued at about $30,000. Proficio Capital Partners LLC raised its position in Humana by 81.4% in the fourth quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 48 shares during the period. We Are One Seven LLC purchased a new position in Humana in the fourth quarter valued at about $31,000. Destination Wealth Management raised its position in Humana by 130.0% in the first quarter. Destination Wealth Management now owns 115 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 65 shares during the period. Finally, Exane Asset Management purchased a new position in Humana in the fourth quarter valued at about $43,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.
About Humana (NYSE:HUM)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also: Economic Reports
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.